Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Material-Sparing Strategies for Rapid Development and Scale-Up of Complex Drug Products
In an industry where complex molecules and first-in-human (FIH) formulations often come with very limited API supply, material-sparing strategies are central to efficient CMC development. read more
How Sports Stars and Drugs Keep Getting Reinvented
Reinvention is everywhere. Products get updated, industries change course, and ideas we once treated as finished suddenly come back in a new form. Something that felt permanent five years ago can look completely different today, redesigned for a new audience or a new moment. read more
Safely Scaling Highly Potent API manufacturing
Ever more drug developers are searching for CDMOs with contamination-limiting capabilities. But how can they know which have these high-potency credentials? read more
The Operational Foundations That Characterize Regulatory Leaders
Holding individuals and teams explicitly accountable for data accuracy and quality might seem straightforward, but it is difficult to sustain in practice. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Ecolab Opens Resin Manufacturing Facility in China
Tuesday, September 15, 2026
Ecolab Life Sciences has opened a resin manufacturing facility in Quzhou, China, expanding the company’s capacity to produce materials used in ... read more
Endpoint Clinical Acquires Bluefin
Tuesday, September 15, 2026
Endpoint Clinical has acquired Bluefin, a provider of clinical supply forecasting and planning technology. read more
FAREVA Acquires Pharmaceutical Manufacturing Site in Türkiye
Tuesday, September 15, 2026
FAREVA has acquired a pharmaceutical production site in Lüleburgaz, Türkiye, expanding its manufacturing network and adding nearly 750 employees. read more
Sygnature Discovery Establishes DEL Screening Collaboration with X-Chem
Monday, September 14, 2026
Sygnature Discovery has established a formal collaboration with X-Chem to support the delivery of DEL screening within its integrated drug discovery ... read more
Transcenta Licenses Continuous Bioprocessing Technology to WuXi Biologics
Thursday, September 10, 2026
Transcenta Therapeutics and WuXi Biologics have entered a technology licensing and strategic collaboration agreement covering Transcenta’s HiCB ... read more